IMMUNOGENICITY ASSESSMENT FOR LUNG-STAGE AND BIOMPHALARIA ALEXANDRINA COCKTAIL VACCINE IN SCHISTOSOMA MANSONI INFECTED MICE
ABDEL HAMED, E., FATHY, G., SALAMA, M., ATTIA, S., RASHED, H. (2016). IMMUNOGENICITY ASSESSMENT FOR LUNG-STAGE AND BIOMPHALARIA ALEXANDRINA COCKTAIL VACCINE IN SCHISTOSOMA MANSONI INFECTED MICE. EKB Journal Management System, 46(3), 633-645. doi: 10.21608/jesp.2016.88269
ENAS F. ABDEL HAMED; GHADA M. FATHY; MARWA A. SALAMA; SHAHERA M. ATTIA; HAYAM E. RASHED. "IMMUNOGENICITY ASSESSMENT FOR LUNG-STAGE AND BIOMPHALARIA ALEXANDRINA COCKTAIL VACCINE IN SCHISTOSOMA MANSONI INFECTED MICE". EKB Journal Management System, 46, 3, 2016, 633-645. doi: 10.21608/jesp.2016.88269
ABDEL HAMED, E., FATHY, G., SALAMA, M., ATTIA, S., RASHED, H. (2016). 'IMMUNOGENICITY ASSESSMENT FOR LUNG-STAGE AND BIOMPHALARIA ALEXANDRINA COCKTAIL VACCINE IN SCHISTOSOMA MANSONI INFECTED MICE', EKB Journal Management System, 46(3), pp. 633-645. doi: 10.21608/jesp.2016.88269
ABDEL HAMED, E., FATHY, G., SALAMA, M., ATTIA, S., RASHED, H. IMMUNOGENICITY ASSESSMENT FOR LUNG-STAGE AND BIOMPHALARIA ALEXANDRINA COCKTAIL VACCINE IN SCHISTOSOMA MANSONI INFECTED MICE. EKB Journal Management System, 2016; 46(3): 633-645. doi: 10.21608/jesp.2016.88269

IMMUNOGENICITY ASSESSMENT FOR LUNG-STAGE AND BIOMPHALARIA ALEXANDRINA COCKTAIL VACCINE IN SCHISTOSOMA MANSONI INFECTED MICE

Journal of the Egyptian Society of Parasitology
Article 20, Volume 46, Issue 3, December 2016, Page 633-645  XML PDF (439.82 K)
Document Type: Original Article
DOI: 10.21608/jesp.2016.88269
View on SCiNiTO View on SCiNiTO
Authors
ENAS F. ABDEL HAMED1; GHADA M. FATHY1; MARWA A. SALAMA1; SHAHERA M. ATTIA2; HAYAM E. RASHED3
1Department of Medical Parasitology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
2Department of Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
3Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Abstract
The availability of a new vaccine is usually needed as an additional component to chemotherapy for control of schistosomiasis. Different strategies of different types of vaccines were assessed to decrease morbidity but did not give the best protection. The study assessed the efficacy of BAAP, SLAP and their combined preparations together with BCG adjuvant as an effective anti-schistosomal vaccine. Methodology: Six groups of Swiss albino mice were used; (G1) as a
control, (G2) infected non immunized; (G3) infected and supported by Adj.; (G4) infected; vaccinated with BAAP and supported by Adj.; (G5) infected, vaccinated with SLAP and supported by Adj. and the target group (G6) infected, vaccinated with combined antigens (BAAP + SLAP) and supported by Adjuvant. Mice were sacrificed 8 weeks post infection for assessment the effect of our vaccine through parasitological, histopathological, serological and immunohistochemical
study. The vaccination of mice with BAAP, SLAP and Adjuvant followed by challenge S. mansoni infection resulted in highest reduction percentages (92% & 86%) for mean numbers of adult burdens and fecal egg counts respectively,(82.4%, 81%) for granuloma number and diameter respectively compared with other groups. The improvement % of all measured enzymes was higher in G6 than other groups.IL10 was significantly increased in G6 than other groups; also,
TNF was significantly decreased in G6 than other groups.
Keywords
Egypt, Sharkia Governorate, Schistosoma mansoni, Lung schistosomulum; Biomphalaria alexandrina, Vaccine, Immunohistochemistry, TNF-α, IL-10
Statistics
Article View: 163
PDF Download: 245